JPRN-UMIN000001358
Completed
Phase 2
A Phase II Study of carboplatin plus paclitaxel for advanced thymic cancer - Carboplatin plus paclitaxel for advanced thymic cancer
ConditionsThymic cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Thymic cancer
- Sponsor
- West Japan Oncology Group
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Presence of pleural or pericardial effusion that cannot be controlled by a procedure. 2\)Presence of brain tumor with clinical symptoms. 3\)Superior vena cava syndrome. 4\)Interstitial pneumonitis. 5\)Presence of other active malignancy. 6\)Acute intercurrent infection or complications 7\)History of serious allergy to medical drugs. 8\)Uncontrolled psychiatric disease. 9\)pregnancy or lactating patients 10\)Myasthenia gravis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
A Phase II study of Paclitaxel plus Carboplatin plus Bevacizumab that introduces concept of Clinical PD in recurrent or advanced non-squamous non-small cell lung cancer.recurrent or advanced non-squamous non-small-cell and lung cancer.JPRN-UMIN000005328Dept. of Respiratory Medicine, Osaka University Hospital45
Active, not recruiting
Not Applicable
A phase II trial of carboplatin and paclitaxel compared with carboplatin or gemcitabine paclitaxel induction followed by carboplatin/paclitaxel/gemcitabine in patients with suboptimally resected stage III or IV ovarian carcinoma - NDEUCTR2006-000126-31-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Active, not recruiting
Not Applicable
Study of Carboplatin-Paclitaxel, with or without ISIS 183750 (an eIF4E Inhibitor), in Patients with Stage IV Non-Small Cell Lung Cancer, Phase 1b/2EUCTR2010-022240-21-HUIsis Pharmaceuticals Inc.118
Completed
Phase 2
Phase 2 study of Carboplatin plus nab-Paclitaxel for patients with PS 2 advanced NSCLC(TORG1426)on small cell lung cancerJPRN-UMIN000019458PO Thoracic Oncology Research Group42
Completed
Phase 2
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90